Supira Medical (Series E)
Funding Details
Awarder
Inbox
Date Award
May 17, 2025
Vertical
Cardiovascular
Funding Amount
$120,000,000
Company Info
Traction
Completed enrollment for the U.S. SUPPORT I Early Feasibility Study (EFS) evaluating its pVAD.
Market
Medical Devices
Location
Los Gatos, California, USA
Coinvestors
Novo Holdings, Qatar Investment Authority, Cormorant Asset Management, The Capital Partnership, 415 Capital, AMED Ventures, PA MedTech VC fund, Unorthodox Ventures
Company Description

Supira Medical is a clinical-stage company developing a percutaneous ventricular assist device (pVAD) aimed at treating high-risk percutaneous coronary intervention (HRPCI) and cardiogenic shock (CS). The device features a high-flow, low-profile catheter pump with real-time monitoring to minimize vascular complications.

Links